trending Market Intelligence /marketintelligence/en/news-insights/trending/749ZIUyKEmQVhLXIl2ra2g2 content esgSubNav
In This List

Varian receives US, German antitrust clearances for Sirtex acquisition

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Varian receives US, German antitrust clearances for Sirtex acquisition

Varian Medical Systems Inc. said it received clearances from the U.S. antitrust authorities and the German Federal Cartel Office for the proposed acquisition of Sirtex Medical Ltd.

Palo Alto, Calif.-based Varian Medical had agreed to buy the Australian life sciences company for A$1.59 billion.

The transaction, which is expected to close in late May, is still subject to the approval of the Sirtex shareholders, the Federal Court of Australia and other customary closing conditions, including other applicable regulatory approvals.